Table of Contents Author Guidelines Submit a Manuscript
Journal of Tropical Medicine
Volume 2012, Article ID 518564, 6 pages
http://dx.doi.org/10.1155/2012/518564
Clinical Study

Plasma Level of IL-4 Differs in Patients Infected with Different Modern Lineages of M. tuberculosis

1Armauer Hansen Research Institute, P.O. Box 1005, Addis Ababa, Ethiopia
2Department of Microbiology, Immunology and Parasitology, School of Medicine, College of Health Sciences, Addis Ababa University, P.O. Box 9086, Addis Ababa, Ethiopia
3Division of Molecular Biology and Human Genetics, DST/NRF Centre of Excellence for Biomedical Tuberculosis Research, MRC Centre for Molecular and Cellular Biology, Faculty of Medicine and Health Sciences, Stellenbosch University, P.O. Box 19063, Francie van Zijl Drive, Tygerberg 7505, South Africa

Received 24 July 2012; Accepted 22 August 2012

Academic Editor: Marcel Tanner

Copyright © 2012 Adane Mihret et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. World Health Organization, “Global tuberculosis control,” WHO Report, World Health Organization, Geneva, Switzerland, 2011. View at Google Scholar
  2. R. Bellamy, “Susceptibility to mycobacterial infections: the importance of host genetics,” Genes and Immunity, vol. 4, no. 1, pp. 4–11, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. M. P. Nicol and R. J. Wilkinson, “The clinical consequences of strain diversity in Mycobacterium tuberculosis,” Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 102, no. 10, pp. 955–965, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Coscolla and S. Gagneux, “Does M. tuberculosis genomic diversity explain disease diversity?” Drug Discovery Today, vol. 7, no. 1, pp. e43–e59, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Gagneux and P. M. Small, “Global phylogeography of Mycobacterium tuberculosis and implications for tuberculosis product development,” The Lancet Infectious Diseases, vol. 7, no. 5, pp. 328–337, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Gagneux, K. DeRiemer, T. Van et al., “Variable host-pathogen compatibility in Mycobacterium tuberculosis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 8, pp. 2869–2873, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. A. E. Hirsh, A. G. Tsolaki, K. DeRiemer, M. W. Feldman, and P. M. Small, “Stable association between strains of Mycobacterium tuberculosis and their human host populations,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 14, pp. 4871–4876, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. C. Manca, M. B. Reed, S. Freeman et al., “Differential monocyte activation underlies strain-specific Mycobacterium tuberculosis pathogenesis,” Infection and Immunity, vol. 72, no. 9, pp. 5511–5514, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Tanveer, Z. Hasan, A. Kanji, R. Hussain, and R. Hasan, “Reduced TNF-α and IFN-γ responses to Central Asian strain 1 and Beijing isolates of Mycobacterium tuberculosis in comparison with H37Rv strain,” Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 103, no. 6, pp. 581–587, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. B. López, D. Aguilar, H. Orozco et al., “A marked difference in pathogenesis and immune response induced by different Mycobacterium tuberculosis genotypes,” Clinical and Experimental Immunology, vol. 133, no. 1, pp. 30–37, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Hanekom, G. D. Van Der Spuy, E. Streicher et al., “A recently evolved sublineage of the Mycobacterium tuberculosis Beijing strain family is associated with an increased ability to spread and cause disease,” Journal of Clinical Microbiology, vol. 45, no. 5, pp. 1483–1490, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. B. C. de Jong, P. C. Hill, A. Aiken et al., “Progression to active tuberculosis, but not transmission, varies by Mycobacterium tuberculosis lineage in the Gambia,” Journal of Infectious Diseases, vol. 198, no. 7, pp. 1037–1043, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. N. Rakotosamimanana, V. Raharimanga, S. F. Andriamandimby et al., “Variation in gamma interferon responses to different infecting strains of Mycobacterium tuberculosis in acid-fast bacillus smear-positive patients and household contacts in Antananarivo, Madagascar,” Clinical and Vaccine Immunology, vol. 17, no. 7, pp. 1094–1103, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. D. Portevin, S. Gagneux, I. Comas, and D. Young, “Human macrophage responses to clinical isolates from the Mycobacterium tuberculosis complex discriminate between ancient and modern lineages,” PLoS Pathogens, vol. 7, no. 3, Article ID e1001307, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. R. Brosch, S. V. Gordon, M. Marmiesse et al., “A new evolutionary scenario for the Mycobacterium tuberculosis complex,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 6, pp. 3684–3689, 2002. View at Publisher · View at Google Scholar · View at Scopus
  16. C. Manca, L. Tsenova, C. E. Barry et al., “Mycobacterium tuberculosis CDC1551 induces a more vigorous host response in vivo and in vitro, but is not more virulent than other clinical isolates,” Journal of Immunology, vol. 162, no. 11, pp. 6740–6746, 1999. View at Google Scholar · View at Scopus
  17. L. Tsenova, E. Ellison, R. Harbacheuski et al., “Virulence of selected Mycobacterium tuberculosis clinical isolates in the rabbit model of meningitis is dependent on phenolic glycolipid produced by the bacilli,” Journal of Infectious Diseases, vol. 192, no. 1, pp. 98–106, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. C. Manca, L. Tsenova, A. Bergtold et al., “Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-α/β,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 10, pp. 5752–5757, 2001. View at Publisher · View at Google Scholar · View at Scopus
  19. C. Manca, L. Tsenova, S. Freeman et al., “Hypervirulent M. tuberculosis W/Beijing strains upregulate Type I IFNs and increase expression of negative regulators of the jak-stat pathway,” Journal of Interferon and Cytokine Research, vol. 25, no. 11, pp. 694–701, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. R. Chacon-Salinas, J. Serafin-Lopez, R. Ramos-Payan et al., “Differential pattern of cytokine expression by macrophages infected in vitro with different Mycobacterium tuberculosis genotypes,” Clinical and Experimental Immunology, vol. 140, pp. 443–449, 2005. View at Google Scholar
  21. S. M. Newton, R. J. Smith, K. A. Wilkinson et al., “A deletion defining a common Asian lineage of Mycobacterium tuberculosis associates with immune subversion,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 42, pp. 15594–15598, 2006. View at Publisher · View at Google Scholar · View at Scopus